Avesthagen Enters North American Market.BANGALORE, India -- Avesthagen announced today its plans to enter the US market with its line of proprietary medicinal extracts. The company, based in India, has a systematic approach for developing stable and reliable extracts from plants used in traditional herbal medicine herbal medicine, use of natural plant substances (botanicals) to treat and prevent illness. The practice has existed since prehistoric times and flourishes today as the primary form of medicine for perhaps as much as 80% of the world's population. in Asia. The Avesthagen system applies scientific principles utilized in drug development to discover products with clinically-proven efficacy for specific health conditions. Avesthagen manufactures its proprietary extracts for functional food manufacturers and dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement marketing companies. The company already collaborates with a number of world-class pharmaceutical and food manufacturers based outside of the US, such as Nestle, Danone, Novartis and AstraZeneca. Avesthagen is now seeking North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. partners for the development of new extracts or to market those already available. Avesthagen currently has medicinal extracts with strong efficacy in two health conditions of particular concern in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. : Type 2 diabetes type 2 diabetes n. See diabetes mellitus. and bone health. The company has discovered several extracts that improve the glycemic index gly·ce·mic index n. An index that measures the ability of a given food to elevate blood sugar. glycemic index, n of foods. Reducing the glycemic index reduces insulin demand and it is widely believed that this can delay the onset of Type 2 diabetes and assist in the management of the condition once established. The extracts perform as well as leading drugs sold for the same purpose. The Avesthagen bone health product shows promise for arresting the loss of bone density, a pronounced problem in mature women, and, unlike most remedies, has been shown to actually rebuild bone density. This product could be incorporated in foods in the same manner that calcium is now added for this purpose, or taken as a supplement. About Avesthagen: Avesthagen was founded in 1998 by one of India's pioneers and leading biotech entrepreneurs Dr. Villoo Morawala-Patell, who got her Ph.D. from Louis Pasteur University in Strasbourg, France, in 1993. It began business operations Business operations are those activities involved in the running of a business for the purpose of producing value for the stakeholders. Compare business processes. The outcome of business operations is the harvesting of value from assets officially in 2001. Since its inception Avesthagen has grown into one of India's leading healthcare technology groups in India, and its activities include, in addition to its agri-biotechnologies product pipeline, development of scientifically validated bioactive bi·o·ac·tive adj. Of or relating to a substance that has an effect on living tissue. bioactive having an effect on or eliciting a response from living tissue. nutraceuticals, derived from Indian medicinal plants medicinal plants, plants used as natural medicines. This practice has existed since prehistoric times. There are three ways in which plants have been found useful in medicine. , as well as the development of a pipeline of bio-similar drugs. Avesthagen has four strategic business units: Biopharmaceuticals, Food For Medicine (Nutraceuticals), Seed For Food (agribiotech) and Science Innovation. Avesthagen's partners include multiple top 10 global companies in each of its fields of research. Avesthagen collaborates at every stage in the value chain with appropriate partners, both public and private, for access to and exchange of technology and overall commercial expertise to leverage the 'India advantage'. Avesthagen employs 250 people worldwide. For Avesthagen on the web: www.avesthagen.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion